Nigel Parker
Impact in
- Genetics top 10%
- Virus-based gene therapy research
-
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Viral Infectious Diseases and Gene Expression in Insects
- Advanced biosensing and bioanalysis techniques
Papers in
- Surgery 10
- Bladder and Urothelial Cancer Treatments 10
- Urinary and Genital Oncology Studies 3
-
- RNA Interference and Gene Delivery 3
- Co-authors
- Seppo Ylä‐Herttuala (16 shared papers)Thomas Wirth (1 shared paper)Hanna P. Lesch (5 shared papers)Hanna Leinonen (3 shared papers)Tommi Heikura (5 shared papers)Igor Oruetxebarria (2 shared papers)Sharada Mokkapati (8 shared papers)David J. McConkey (8 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Human Gene Therapy (2 papers)The Journal of Urology (2 papers)European Urology (2 papers)Molecular Therapy — Methods & Clinical Development (2 papers)
- Partner nations
- FinlandUnited StatesUnited Kingdom
In The Last Decade
Nigel Parker
19 papers receiving 568 citations
Peers
Comparison fields: 5 of 82
- Genetics 284
- Molecular Biology 451
- Business and International Management 9
- Oncology 120
- Biotechnology 28
Countries citing papers authored by Nigel Parker
This map shows the geographic impact of Nigel Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Parker more than expected).
Fields of papers citing papers by Nigel Parker
This network shows the impact of papers produced by Nigel Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Parker. The network helps show where Nigel Parker may publish in the future.
Co-authors
The 25 scholars most cited alongside Nigel Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 406 | |
| 2 | 2020 | 49 | |
| 3 | 2015 | 34 | |
| 4 | 2020 | 23 | |
| 5 | 2018 | 20 | |
| 6 | 2020 | 19 | |
| 7 | 2019 | 19 | |
| 8 | 2019 | 10 | |
| 9 | 2011 | 3 | |
| 10 | 2020 | 3 | |
| 11 | 2024 | 2 | |
| 12 | 2016 | 2 | |
| 13 | 2021 | 1 | |
| 14 | 2017 | 1 | |
| 15 | 2022 | 1 | |
| 16 | 2019 | 1 | |
| 17 | 2021 | 1 | |
| 18 | 2018 | 1 | |
| 19 | 2020 | 1 | |
| 20 | 2024 | 0 |
About Nigel Parker
Nigel Parker is a scholar working on Surgery, Molecular Biology, Oncology, Genetics and Immunology, having authored 20 papers that have together received 597 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (10 papers), Virus-based gene therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immune cells in cancer (4 papers), Cancer Research and Treatments (3 papers), CAR-T cell therapy research (3 papers), RNA Interference and Gene Delivery (3 papers) and Urinary and Genital Oncology Studies (3 papers). The work is most often cited by research in Genetics (284 citations), Molecular Biology (451 citations), Business and International Management (9 citations), Oncology (120 citations) and Biotechnology (28 citations). Nigel Parker has collaborated with scholars based in Finland, United States and United Kingdom. Frequent co-authors include Seppo Ylä‐Herttuala, Thomas Wirth, Hanna P. Lesch, Hanna Leinonen, Tommi Heikura, Igor Oruetxebarria, Sharada Mokkapati, David J. McConkey, Colin P. Dinney and Kimberly S. Schluns. Their work appears in journals such as Journal of Clinical Oncology, Human Gene Therapy, The Journal of Urology, European Urology and Molecular Therapy — Methods & Clinical Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.